Assignee
LINDHOFER HORST
DE·6 granted patents·4 pending applications·72 citations·filing 2003–2018
Top patents by PatentIndex Score
10 records- 0196US9017676B2Destruction of tumor cells by trifunctional bispecific antibodies with low to medium expression levels of tumor-associated target antigensLINDHOFER HORST·Filed 2007·Granted Apr 28, 2015·32 cites·18 claims
- 0289US8277806B2Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascitesLINDHOFER HORST·Filed 2003·Granted Oct 2, 2012·19 cites·14 claims
- 0385US8663638B2Intraoperative trifunctional antibody application for prophylaxis of intraperitoneal tumor cell disseminationLINDHOFER HORST·Filed 2008·Granted Mar 4, 2014·7 cites·20 claims
- 0481US9750806B2Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer propertiesLINDHOFER HORST·Filed 2012·Granted Sep 5, 2017·2 cites·23 claims
- 0578US8066989B2Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapyLINDHOFER HORST·Filed 2004·Granted Nov 29, 2011·9 cites·15 claims
- 0676US9772327B2Initial relative lymphocyte count as predictive biomarkerLINDHOFER HORST·Filed 2012·Granted Sep 26, 2017·3 cites·16 claims
- 0753US2019375852A1Combination Of T-Cell Redirecting Multifunctional Antibodies With Immune Checkpoint Modulators And Uses ThereofLINDHOFER HORST·Filed 2017·Application pending·0 cites
- 0842US2019054170A1Multispecific antibodies for use in the treatment of a neoplasm of the urinary tractLINDHOFER HORST·Filed 2018·Application pending·0 cites
- 0941US2017224818A1Subcutaneously administered bispecific antibodies for use in the treatment of cancerLINDHOFER HORST·Filed 2015·Application pending·0 cites
- 1036US2012095192A1Use of trifunctional bispecific antibodies for the treatment of tumors associated with the cd133+/epcam+ cancer stem cellsLINDHOFER HORST·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →